bioMerieux SA
https://www.biomerieux.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From bioMerieux SA
The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics
With COVID-19 a residual but still very real issue globally, Novo Holdings asked the big diagnostics question at a recent high-level roundtable: How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? The CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.
APACMed: Johnson & Johnson On Using ‘Big’ For Good In The COVID-19 Challenge
Johnson & Johnson's Ashley McEvoy explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.
Using ‘Big’ For Good In The COVID-19 Challenge
Johnson & Johnson, among world’s largest health care groups, explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.
Biopharma COVID-19 Collaborations May Avoid Antitrust Hurdles, FTC And DOJ Suggest
FTC and DoJ issue guidance for businesses working together to tackle coronavirus pandemic; BIO is 'pleased' they intend to help facilitate critical partnerships.
Company Information
- Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Saliva-based Testing
- Urine-based Testing
- Other Names / Subsidiaries
-
- Astute Medical, Inc.
- BioFire Diagnostics
- bioMérieux, Inc.
- bioTheranostics
- Idaho Technology
- Organon Teknika
- Vitek Systems
- bioMerieux Deutschland GmbH
- bioMerieux Austria GmbH
- bioMerieux Benelux SA/NV
- Organon Teknika